Description
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
This trial is available at multiple Sutter Locations. Please contact one of the following about Study NRG GU005
San Francisco: ClinicalResearch@sutterhealth.org
Palo Alto/Santa Cruz: Tanya Pozniansky pozniat@sutterhealth.org
East Bay: James Nasman NasmanJ@sutterhealth.org and Vivian Leong, RN Leongv@sutterhealth.org
Sacramento: Isabel Rodrigues-Fong Rodrigi@sutterhealth.org and Kirsten Babski babskik@sutterhealth.org
Modesto: Delia Massone MassonD@sutterhealth.org and Adrienne Palos PalosA@sutterhealth.org
Solano-Vallejo Cancer Center: Stephanie Gonzales gonzals1@sutterhealth.org
San Mateo:Stephanie Casal CasalSL@sutterhealth.org andBonnie Chan ChanBW@sutterhealth.org
Santa Rosa:Patricia Grinnell GrinneP@sutterhealth.org andMohammad Naseem NaseemMK@sutterhealth.org
View study details on ClinicalTrials.gov
Principal Investigator
Recruitment Status
Active, Recruiting
Start Date
February 01, 2019
Related Studies
Genomic Health Oncotype DX AR-V7
Investigators: Vijay Suhag, M.D., Kristie A. Bobolis, M.D., Nitin Rohatgi, MD, Sivakumar Reddy, M.D., Rajeswari Chellappah, M.D., David S Yee, M.D., MPH, Brian K. Kim, M.D, Kristin N. Arreola, M.D.